Phase III study of intravenous immunglobulin (IVIG) in patients with heart failure after myocardial infarction.
Phase of Trial: Phase III
Latest Information Update: 24 Jan 2014
At a glance
- Drugs Immunoglobulins
- Indications Heart failure
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 Jul 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Feb 2007 New trial record.